Procter & Gamble Reportedly Eyed Gillette Merger
After an unsolicited bid for Gillette (G) was rejected, Procter & Gamble (PG) appears to be turning to drugs, according to a Wall Street Journal report Monday.
The report said P&G chief Durk Jager, who has promised big changes at the sometimes stodgy consumer products giant, decided not to aggressively pursue the French company best known for its razor blades, and instead looked to other possible acquisition targets. The targets turned out to be American Home Products (AHP) and Warner-Lambert (WLA), and talks with P&G are said to have continued through the weekend. Many expect an announcement will come possibly as soon as Monday. Rumors and speculation over a possible takeover of the drug makers by P&G have circulated for over a week, and have hurt shares of P&G as investors have questioned the sometimes risky and always cut-throat drug trade. P&G shares dropped nearly 9% last Friday, and are seen opening lower Monday. If a deal is announced, P&G could be seen as a white knight who comes to break up what has become a bitter battle between drug maker Pfizer (PFE) and Warner-Lambert. After agreeing to a $57 billion purchase of AHP in early November, Warner-Lambert has been locked in a battle after it repeatedly rejected a $79 billion bid from Pfizer. Warner-Lambert reluctantly decided on Jan. 13 to negotiate with Pfizer. The purchase would be P&G's largest acquisition ever, and would essentially mark its entry into the pharmaceuticals business, which currently accounts for only about 2% of its business. Cincinnati-based P&G is best known for its tried and true consumer products lines such as Tide detergent, Crest toothpaste and Scope mouthwash, while Morris Plains, N.J.-based Warner-Lambert's lines include Sudafed and Listerine mouthwash. AHP has the popular over-the-counter pain relievers Advil and Anacin, and prescription hormone drug Premarin. Last year, P&G bought pet food maker Iams for $2.3 billion.>To order reprints of this article, click here: ReprintsTheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,890.46 | 1,351.95 | 2,927.23 | 20.47 |
Oil *
118.75
|
|
UP
6.51 |
UP
1.99 |
UP
11.37 |
UP
0.72 |
10 Yr
2.05%
SPDR Gold
168.02
|
|
+0.05%
|
+0.15%
|
+0.39%
|
+3.65%
|
Data delayed 20 minutes |

Connect with TheStreet